BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL

N. Ruperto; H. Brunner; T. Constantin; N. Wulffraat; G. Horneff; J. Anton; R. Berner; F. Corona; R. Cuttica; M. Desjonqueres; M. Fischbach; M. Alessio; A. Chieng; W. Emminger; E. Haddad; K. Lheritier; K. Abrams; J. Hruska; D. Kim; A. Martini; D. Lovell

BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL

N. Ruperto, H. Brunner, T. Constantin, N. Wulffraat, G. Horneff, J. Anton, R. Berner, F. Corona, R. Cuttica, M. Desjonqueres, M. Fischbach, M. Alessio, A. Chieng, W. Emminger, E. Haddad, K. Lheritier, K. Abrams, J. Hruska, D. Kim, A. MartiniD. Lovell

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	97-98
Journal	Annals of the Rheumatic Diseases
Volume	72
Publication status	Published - Jun 2013

Cite this

Ruperto, N., Brunner, H., Constantin, T., Wulffraat, N., Horneff, G., Anton, J., Berner, R., Corona, F., Cuttica, R., Desjonqueres, M., Fischbach, M., Alessio, M., Chieng, A., Emminger, W., Haddad, E., Lheritier, K., Abrams, K., Hruska, J., Kim, D., ... Lovell, D. (2013). BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL. Annals of the Rheumatic Diseases, 72, 97-98.

@article{2f9b4797609240abb4d294657c26f8a6,

title = "BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL",

author = "N. Ruperto and H. Brunner and T. Constantin and N. Wulffraat and G. Horneff and J. Anton and R. Berner and F. Corona and R. Cuttica and M. Desjonqueres and M. Fischbach and M. Alessio and A. Chieng and W. Emminger and E. Haddad and K. Lheritier and K. Abrams and J. Hruska and D. Kim and A. Martini and D. Lovell",

year = "2013",

month = jun,

language = "English",

volume = "72",

pages = "97--98",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

}

Ruperto, N, Brunner, H, Constantin, T, Wulffraat, N, Horneff, G, Anton, J, Berner, R, Corona, F, Cuttica, R, Desjonqueres, M, Fischbach, M, Alessio, M, Chieng, A, Emminger, W, Haddad, E, Lheritier, K, Abrams, K, Hruska, J, Kim, D, Martini, A & Lovell, D 2013, 'BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL', Annals of the Rheumatic Diseases, vol. 72, pp. 97-98.

BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL. / Ruperto, N.; Brunner, H.; Constantin, T. et al.
In: Annals of the Rheumatic Diseases, Vol. 72, 06.2013, p. 97-98.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - BASELINE CHARACTERISTICS OF PATIENTS WITH ACTIVE SYSTEMIC JIA SUCCESSFULLY DISCONTINUING CORTICOSTEROID WHILE RECEIVING CANAKINUMAB: SECONDARY ANALYSIS FROM A PIVOTAL PHASE 3 TRIAL

AU - Ruperto, N.

AU - Brunner, H.

AU - Constantin, T.

AU - Wulffraat, N.

AU - Horneff, G.

AU - Anton, J.

AU - Berner, R.

AU - Corona, F.

AU - Cuttica, R.

AU - Desjonqueres, M.

AU - Fischbach, M.

AU - Alessio, M.

AU - Chieng, A.

AU - Emminger, W.

AU - Haddad, E.

AU - Lheritier, K.

AU - Abrams, K.

AU - Hruska, J.

AU - Kim, D.

AU - Martini, A.

AU - Lovell, D.

PY - 2013/6

Y1 - 2013/6

M3 - Meeting Abstract

SN - 0003-4967

VL - 72

SP - 97

EP - 98

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

ER -